Daxor Corporation Announces the Formation of Daxor Capital; New Division Will Provide Equipment Financing for BVA-100.Business Editors/Health/Medical Writers NEW YORK--(BUSINESS WIRE)--Jan. 8, 2003 Daxor Corporation, (AMEX AMEX See: American Stock Exchange : DXR DXR Danbury Municipal Airport, Danbury CT (airport code) DXR Data Extraction and Recording DXR X-Director DXR Dynamic Extended Resolution ), a leading medical instrumentation and biotechnology company, today announced the formation of Daxor Capital to provide equipment financing for the BVA-100 Blood Volume Analyzer and other products and services. "We are very pleased to announce the formation of this financing entity," said Dr. Joseph Feldschuh, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Daxor Corporation. "Daxor Capital will expand the availability of the products and services offered by our company and strengthen our overall position in the marketplace, in addition to providing a more complete solution for our customers. Several flexible equipment leasing or financing options are available. Given the growing demand for the BVA-100, (the first FDA-approved semi-automated Blood Volume Analyzer), the formation of Daxor Capital will ensure that we can continue to deliver the best blood volume analysis solutions." Lease financing for Daxor Capital will be provided by De Lage Landen Financial Services of Wayne, PA, which is a subsidiary of Dutch Rabobank Group - one of the world's largest banks and a leading international provider of high quality asset-based financing Asset-based financing Methods of financing in which lenders and equity investors look principally to the cash flow from a particular asset or set of assets for a return on, and the return of, their financing. products to manufacturers and distributors of capital goods Capital Goods Any goods used by an organization to produce other goods. Notes: Examples of capital goods include office buildings, equipment, and machinery. See also: Capital Expenditure, Disinvestment Capital goods . Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use diagnostic kit. It is the first instrument to provide rapid, direct measurement of a patient's blood volume with a high degree of precision. Among nationally renowned hospitals using the BVA-100 Blood Volume Analyzer are NYU NYU New York University NYU New York Undercover (TV show) Medical Center, The Mayo Clinic and The Cleveland Clinic, as well as other major medical institutions. More information about the BVA-100 and other Daxor products and services can be found at www.daxor.com. De Lage Landen Financial Services is part of De Lage Landen International B.V., an international provider of high-quality asset-based financing products. The company, headquartered in Eindhoven (the Netherlands), is a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of the Dutch Rabobank Group. Credit ratings of the major international ratings agencies show that Rabobank is the most credit worthy privately held bank in the world. With offices and joint ventures in 20 countries throughout Europe, the Americas, Australia and New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. , De Lage Landen specializes in asset financing Asset Financing Using balance sheet assets (such as accounts receivable, short-term investments or inventory) to obtain a loan or borrow money - the borrower provides a security interest in the assets to the lender. and vendor finance programs internationally, with a focus on the following industries: Agriculture and Food, Healthcare, IT, Materials Handling and Construction Equipment, Office Equipment, Telecom and Bank Outsourcing. Domestically, the company concentrates on a broad range of leasing and trade finance products. In 2001 De Lage Landen grew its net profit to (euro) 92.2 million (US $82.4 million) and its balance sheet to (euro)10.6 billion (US $9.4 billion) in assets. Additional information can be found at www.delagelanden.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion